Celgene completes purchase of Former Merck Property

- Celgene Corporation has completed its purchase of the former Merck & Co., Inc. property located at 556 Morris Ave. The property features 850,000 square feet of administrative office space, and 450,000 square feet of Research & Development space.

The acquisiton by Summit-headquartered Celgene, an integrated, global pharmaceutical company, extends the company’s existing Hilltop City presence beyond its 86 Morris Ave. global headquarters location. 

Combined with the completion of construction of a new 550,000-squar- foot office building at its 86 Morris Ave. location, the purchase allows Celgene to concentrate its New Jersey operations at two campuses in close proximity in Summit.
 
“This acquisition marks an important milestone in our company’s growth in New Jersey and our long relationship as a proud resident of Summit,” said Bob Hugin, Chairman and CEO of Celgene,  “A vibrant biopharmaceutical sector benefits patients, the healthcare system, and our local communities. With this new site, and the soon to be completed new building at our headquarters location, we are building an even stronger presence in this great community.”

Read more here. 

Up Next:


Up Next

  • Celgene completes purchase of Former Merck Property
  • NY launches Puerto Rico relief effort
  • Drone hits Army helicopter over New York
  • An app for positive interactions among kids
  • NTSB: Pilots erred in Pence plane's LaGuardia skid
  • Suspect caught during police chase because he stops for gas
  • Tractor trailer makes wrong turn, gets stuck on boardwalk down shore
  • NJ cop finds woman's engagement ring on highway
  • DC looking into proposal of setting up supervised injection sites for drug users
  • Georgia workers sent to hard-hit Florida Keys